Physician profile
Neera Bhatia
NPI 1760428619
$1,598.15
in general payments reported to CMS, 2019-2025
19 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $196 · 2021: $351 · 2022: $263 · 2023: $284 · 2024: $70.50 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $292.45 | 2021-2022 | |
| Galderma Laboratories, L.P. | $269.15 | 2021-2024 | |
| Pfizer INC. | $198.05 | 2019-2022 | |
| Abbvie INC. | $154.92 | 2020-2023 | Lo Loestrin Fe, Liletta |
| Amgen INC. | $122.33 | 2019-2022 | |
| Lupin INC. | $110.30 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $87.89 | 2019 | |
| Revance Therapeutics, INC. | $79.81 | 2024-2025 | Daxxify |
| Duchesnay USA Incorporated | $51.54 | 2019 | |
| Millicent US INC | $39.34 | 2020-2024 | Intrarosa |
| Astellas Pharma US INC | $33.89 | 2022-2025 | Veozah |
| Mayne Pharma Commercial LLC | $24.21 | 2021 | |
| Biogen, INC. | $23.86 | 2025 | Zurzuvae |
| Novo Nordisk INC | $23.09 | 2025 | Wegovy |
| Shield Therapeutics INC | $20.26 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $18.89 | 2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $18.59 | 2021 | |
| Exact Sciences Corporation | $16.05 | 2025 | The Cologuard Plus Collection Kit |
| Avion Pharmaceuticals | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neera Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.